TREATMENT PATTERNS AND PROGNOSIS OF FIGO STAGE IVB CERVICAL CANCER

被引：0
|
作者：
Hasumi, Y. [1 ]
Kubota, K. [1 ]
Numata, A. [1 ]
Tsukazaki, T. [1 ]
Hashimoto, K. [1 ]
Horie, K. [1 ]
Yokota, H. [1 ]
机构：
[1] Saitama Canc Ctr, Dept Gynecol, Saitama, Japan
来源：
ANNALS OF ONCOLOGY | 2012年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：153 / 153
页数：1
相关论文
共 50 条
  • [41] Understanding of cancer risk differs based on FIGO stage in women with cervical cancer
    Johns, E.
    Sekhon, S.
    Dick, R.
    Hagemann, A. R.
    Thaker, P. H.
    McCourt, C. K.
    Fuh, K. C.
    Powell, M. A.
    Mutch, D. G.
    Kuroki, L. M.
    GYNECOLOGIC ONCOLOGY, 2020, 159 : 175 - 175
  • [42] Histologic study of patterns of cervical involvement in FIGO stage II endometrial carcinoma
    Scurry, J
    Craighead, P
    Duggan, M
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2000, 10 (06) : 497 - 502
  • [43] Positive peritoneal cytology is highly predictive of prognosis and relapse patterns in stage III (FIGO 2009) endometrial cancer
    Milgrom, S. A.
    Kollmeier, M. A.
    Abu-Rustum, N. R.
    Makker, V.
    Gardner, G. J.
    Barakat, R. R.
    Alektiar, K. M.
    GYNECOLOGIC ONCOLOGY, 2013, 130 (01) : 49 - 53
  • [44] The prognostic factors in 384 patients with FIGO 2014 stage IB cervical cancer: What is the role of tumor size on prognosis?
    Yuksel, Dilek
    Sahin, Ediz Karatas
    Unsal, Mehmet
    Cakir, Caner
    Kilic, Cigdem
    Comert, Gunsu Kimyon
    Korkmaz, Vakkas
    Turkmen, Osman
    Turan, Taner
    EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2021, 266 : 126 - 132
  • [45] Clinical tumor diameter and prognosis of patients with FIGO stage IB1 cervical cancer (JCOG0806-A)
    Kato, Tomoyasu
    Takashima, Atsuo
    Kasamatsu, Takahiro
    Nakamura, Kenichi
    Mizusawa, Junki
    Nakanishi, Toru
    Takeshima, Nobuhiro
    Kamiura, Shoji
    Onda, Takashi
    Sumi, Toshiyuki
    Takano, Masashi
    Nakai, Hidekatsu
    Saito, Toshiaki
    Fujiwara, Kiyoshi
    Yokoyama, Masatoshi
    Itamochi, Hiroaki
    Takehara, Kazuhiro
    Yokota, Harushige
    Mizunoe, Tomoya
    Takeda, Satoru
    Sonoda, Kenzo
    Shiozawa, Tanri
    Kawabata, Takayo
    Honma, Shigeru
    Fukuda, Haruhiko
    Yaegashi, Nobuo
    Yoshikawa, Hiroyuki
    Konishi, Ikuo
    Kamura, Toshiharu
    GYNECOLOGIC ONCOLOGY, 2015, 137 (01) : 34 - 39
  • [46] Localization of distant metastases defines prognosis and treatment efficacy in patients with FIGO stage IV ovarian cancer
    Timmermans, Maite
    Sonke, G. S.
    Van de Vijver, K. K.
    Ottevanger, P. B.
    Nijman, H. W.
    van der Aa, M. A.
    Kruitwagen, R. F. P. M.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2019, 29 (02) : 392 - 397
  • [47] The FIGO Stage IVA Versus IVB of Ovarian Cancer: Prognostic Value and Predictive Value for Neoadjuvant Chemotherapy
    Tajik, Parvin
    van de Vrie, Roelien
    Zafarmand, Mohammad H.
    Coens, Corneel
    Buist, Marrije R.
    Vergote, Ignace
    Bossuyt, Patrick M. M.
    Kenter, Gemma G.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2018, 28 (03) : 453 - 458
  • [48] Pelvic organ prolapse stage IV and cervical cancer FIGO IIa
    Reisenauer, Christl
    Wallwiener, Diethelm
    Brucker, Sara Yvonne
    Kraemer, Bernhard
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2017, 295 (06) : 1303 - 1304
  • [49] Results of Curative Concomitant Chemoradiotherapy in Patients With FIGO Stage IVB Cervical Cancer Presenting Para-aortic and Left Supraclavicular Lymph Nodal Metastases
    Jwa, E.
    Kim, Y. S.
    Nam, J. H.
    Kim, Y. T.
    Kim, J. Y.
    Shin, S. S.
    Choi, E. K.
    Kim, J. H.
    Lee, S. W.
    Ahn, S. D.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S531 - S531
  • [50] Epigenetic therapy and cisplatin chemoradiation in FIGO Stage IIIB cervical cancer
    Candelaria, M.
    Cetina, L.
    Perez-Cardenas, E.
    de la Cruz-Hernandez, E.
    Gonzalez-Fierro, A.
    Trejo-Becerril, C.
    Taja-Chayeb, L.
    Chanona, J.
    Arias, D.
    Duenas-Gonzalez, A.
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2010, 31 (04) : 386 - 391
12345